Elektrofi, Inc.

About Elektrofi, Inc.

Elektrofi is a biopharmaceutical formulation technology company focused on revolutionizing the delivery of biologic therapies. Their mission is to untether patients from the burdens of traditional biologic administration by reengineering medicine delivery, particularly through subcutaneous methods, to ensure patients get the medicines they need when they need them.

Products & Services

Hypercon™ Microparticle Platform Technology:A hyper concentration microparticle platform technology designed to revolutionize the delivery of biologic therapies by enabling smarter, subcutaneous medicine delivery to better support patients on their treatment journeys.

Specialties

Biologic therapy delivery Subcutaneous medicine delivery Hyper concentration microparticle technology

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Series C T: - FT: Series C	A: 112250000 MR: - FA: 112.25 Million FAN: 112250000	D: 2024-10-31 FD: 2024-10-31	20 investors

Series C Latest

2024-10-31

$112.2M

20 investors (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

C

Chase Coffman

Chief Executive Officer

J

Joanne Beck

Chief Operating Officer

V

Vikki Sluzky

Chief Technology Officer

P

Paul Brown

Vice President, Drug Product Innovation

L

Lyndon Charles

Vice President, Head of Program Management and Strategy

W

Willow DiLuzio

Vice President, Pharmaceutical Development

View 15 more team members with Pro

Unlock Full Team Directory

Recent News

Elektrofi, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised